Human placental GLUT1 glucose transporter expression and the fetal insulin like growth factor axis in pregnancies complicated by diabetes.
We have previously described regulation of syncytial GLUT1 glucose transporters by IGF I. Despite this, it is not clear what signal regulates transplacental glucose transport. In this report we asked whether changes in GLUT1 expression and glucose transport activity in diabetic pregnancies were associated with alterations in the fetal IGF axis. Cord blood samples and paired syncytial microvillous and basal membranes were isolated from normal term pregnancies and pregnancies characterized by gestational diabetes type A2 (GDM A2) and pre existing insulin dependent diabetes mellitus (IDDM) Circulating IGF I, basal membrane GLUT1 expression and glucose transporter activity were correlated with birth weight, but only in control, not diabetic groups. Basal membrane GLUT1 and transporter activity were correlated with IGF I concentrations in control, but not diabetic groups. IGF binding protein (IGFBP) binding capacity showed a =50% reduction in the diabetic groups compared to control; both showed a higher level of free IGF I. The absence of a correlation between birth weight and factors such as fetal IGF I or GLUT1 expression in the diabetic groups suggests that IGF I stimulated effects may have reached a limiting threshold, such that further increases in IGF I (or GLUT1) are without effect. These data support that fetal IGF I acts as a fetal nutritional signal, modulating placental GLUT1 expression and birth weight via altered levels of fetal circulating IGFBPs. Diabetes appears to exert its effects on fetal and placental factors prior to the third trimester and, despite good glycemic control immediately prior to, and in the third trimester, these effects persist to term.
Biochimica et biophysica acta. Molecular basis of disease